Lung adenocarcinoma harboring concomitant SPTBN1-ALK fusion, c-Met overexpression, and HER-2 amplification with inherent resistance to crizotinib, chemotherapy, and radiotherapy
Lung adenocarcinoma harboring concomitant SPTBN1-ALK fusion, c-Met overexpression, and HER-2 amplification with inherent resistance to crizotinib, chemotherapy, and radiotherapy
复制标题
DOI：
--
复制
发表时间：
2016
影响因子：
28.5
通讯作者：
Li Liu
中科院分区：
文献类型：
--
作者：
Fei-fei Gu;Yong Zhang;Yang-yang Liu;Xiao-hua Hong;Jin-yan Liang;Fan Tong;Jing-song Yang;Li Liu
